These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

836 related items for PubMed ID: 23747045

  • 21. Transient intraneuronal A beta rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice.
    Christensen DZ, Kraus SL, Flohr A, Cotel MC, Wirths O, Bayer TA.
    Acta Neuropathol; 2008 Dec; 116(6):647-55. PubMed ID: 18974993
    [Abstract] [Full Text] [Related]

  • 22. Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse.
    Dinkins MB, Enasko J, Hernandez C, Wang G, Kong J, Helwa I, Liu Y, Terry AV, Bieberich E.
    J Neurosci; 2016 Aug 17; 36(33):8653-67. PubMed ID: 27535912
    [Abstract] [Full Text] [Related]

  • 23. Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer's disease.
    Howlett DR, Bowler K, Soden PE, Riddell D, Davis JB, Richardson JC, Burbidge SA, Gonzalez MI, Irving EA, Lawman A, Miglio G, Dawson EL, Howlett ER, Hussain I.
    Histol Histopathol; 2008 Jan 17; 23(1):67-76. PubMed ID: 17952859
    [Abstract] [Full Text] [Related]

  • 24. An age-related axon terminal pathology around the first olfactory relay that involves amyloidogenic protein overexpression without plaque formation.
    Cai Y, Xue ZQ, Zhang XM, Li MB, Wang H, Luo XG, Cai H, Yan XX.
    Neuroscience; 2012 Jul 26; 215():160-73. PubMed ID: 22542680
    [Abstract] [Full Text] [Related]

  • 25. Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.
    Härtig W, Saul A, Kacza J, Grosche J, Goldhammer S, Michalski D, Wirths O.
    Neuropathol Appl Neurobiol; 2014 Feb 26; 40(2):106-20. PubMed ID: 23566195
    [Abstract] [Full Text] [Related]

  • 26. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
    Moon M, Hong HS, Nam DW, Baik SH, Song H, Kook SY, Kim YS, Lee J, Mook-Jung I.
    J Alzheimers Dis; 2012 Feb 26; 29(3):615-28. PubMed ID: 22269161
    [Abstract] [Full Text] [Related]

  • 27. Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease.
    Wirths O, Breyhan H, Marcello A, Cotel MC, Brück W, Bayer TA.
    Neurobiol Aging; 2010 May 26; 31(5):747-57. PubMed ID: 18657882
    [Abstract] [Full Text] [Related]

  • 28. Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Aβ accumulation and cell death: involvement in hippocampal neuronal loss in Alzheimer's disease.
    Antequera D, Bolos M, Spuch C, Pascual C, Ferrer I, Fernandez-Bachiller MI, Rodríguez-Franco MI, Carro E.
    Neurobiol Dis; 2012 Jun 26; 46(3):682-91. PubMed ID: 22426395
    [Abstract] [Full Text] [Related]

  • 29. Inverse and distinct modulation of tau-dependent neurodegeneration by presenilin 1 and amyloid-beta in cultured cortical neurons: evidence that tau phosphorylation is the limiting factor in amyloid-beta-induced cell death.
    Leschik J, Welzel A, Weissmann C, Eckert A, Brandt R.
    J Neurochem; 2007 Jun 26; 101(5):1303-15. PubMed ID: 17298384
    [Abstract] [Full Text] [Related]

  • 30. Mutant human APP exacerbates pathology in a mouse model of NPC and its reversal by a β-cyclodextrin.
    Maulik M, Ghoshal B, Kim J, Wang Y, Yang J, Westaway D, Kar S.
    Hum Mol Genet; 2012 Nov 15; 21(22):4857-75. PubMed ID: 22869680
    [Abstract] [Full Text] [Related]

  • 31. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK, Park J, Han D, Yang J, Kim A, Woo J, Kim Y, Mook-Jung I.
    Mol Neurodegener; 2018 Jan 16; 13(1):2. PubMed ID: 29338754
    [Abstract] [Full Text] [Related]

  • 32. Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not amyloid-beta and tau pathology.
    Lopes JP, Blurton-Jones M, Yamasaki TR, Agostinho P, LaFerla FM.
    J Alzheimers Dis; 2009 Jan 16; 16(3):541-9. PubMed ID: 19276549
    [Abstract] [Full Text] [Related]

  • 33. Dietary supplementation with S-adenosyl methionine delayed amyloid-β and tau pathology in 3xTg-AD mice.
    Lee S, Lemere CA, Frost JL, Shea TB.
    J Alzheimers Dis; 2012 Jan 16; 28(2):423-31. PubMed ID: 22045486
    [Abstract] [Full Text] [Related]

  • 34. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss.
    Ager RR, Davis JL, Agazaryan A, Benavente F, Poon WW, LaFerla FM, Blurton-Jones M.
    Hippocampus; 2015 Jul 16; 25(7):813-26. PubMed ID: 25530343
    [Abstract] [Full Text] [Related]

  • 35. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease.
    Schmitz C, Rutten BP, Pielen A, Schäfer S, Wirths O, Tremp G, Czech C, Blanchard V, Multhaup G, Rezaie P, Korr H, Steinbusch HW, Pradier L, Bayer TA.
    Am J Pathol; 2004 Apr 16; 164(4):1495-502. PubMed ID: 15039236
    [Abstract] [Full Text] [Related]

  • 36. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF, Blanchard J, Dai CL, Tung YC, LaFerla FM, Iqbal IG, Iqbal K.
    Neurobiol Dis; 2014 Nov 16; 71():110-30. PubMed ID: 25046994
    [Abstract] [Full Text] [Related]

  • 37. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y, Hua L, Yeh CK, Shen L, Ying M, Zhang Z, Liu G, Li S, Chen S, Chen X, Yang X.
    Theranostics; 2020 Nov 16; 10(25):11794-11819. PubMed ID: 33052247
    [Abstract] [Full Text] [Related]

  • 38. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M, Baches S, Gerth J, Bayer TA, Weggen S, Wirths O.
    J Alzheimers Dis; 2015 Nov 16; 44(4):1291-302. PubMed ID: 25408216
    [Abstract] [Full Text] [Related]

  • 39. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
    Oddo S, Caccamo A, Cheng D, Jouleh B, Torp R, LaFerla FM.
    J Neurochem; 2007 Aug 16; 102(4):1053-63. PubMed ID: 17472708
    [Abstract] [Full Text] [Related]

  • 40. Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.
    Dewachter I, van Dorpe J, Spittaels K, Tesseur I, Van Den Haute C, Moechars D, Van Leuven F.
    Exp Gerontol; 2000 Sep 16; 35(6-7):831-41. PubMed ID: 11053674
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 42.